Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4761885
Max Phase: Preclinical
Molecular Formula: C29H38N4O3
Molecular Weight: 490.65
Molecule Type: Unknown
Associated Items:
ID: ALA4761885
Max Phase: Preclinical
Molecular Formula: C29H38N4O3
Molecular Weight: 490.65
Molecule Type: Unknown
Associated Items:
Canonical SMILES: Cc1nn(-c2cc(N[C@H]3CC[C@H](O)CC3)c3c(=O)[nH]c(CC(C)C)cc3c2)c2c1C(=O)CC(C)(C)C2
Standard InChI: InChI=1S/C29H38N4O3/c1-16(2)10-20-11-18-12-21(33-24-14-29(4,5)15-25(35)26(24)17(3)32-33)13-23(27(18)28(36)31-20)30-19-6-8-22(34)9-7-19/h11-13,16,19,22,30,34H,6-10,14-15H2,1-5H3,(H,31,36)/t19-,22-
Standard InChI Key: OPZDAKPINHFRBW-XYWHTSSQSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 490.65 | Molecular Weight (Monoisotopic): 490.2944 | AlogP: 5.09 | #Rotatable Bonds: 5 |
Polar Surface Area: 100.01 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 3 |
#RO5 Violations: 1 | HBA (Lipinski): 7 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 12.52 | CX Basic pKa: 2.74 | CX LogP: 4.19 | CX LogD: 4.19 |
Aromatic Rings: 3 | Heavy Atoms: 36 | QED Weighted: 0.46 | Np Likeness Score: -0.62 |
1. Mishra SJ,Liu W,Beebe K,Banerjee M,Kent CN,Munthali V,Koren J,Taylor JA,Neckers LM,Holzbeierlein J,Blagg BSJ. (2021) The Development of Hsp90β-Selective Inhibitors to Overcome Detriments Associated with pan-Hsp90 Inhibition., 64 (3.0): [PMID:33428418] [10.1021/acs.jmedchem.0c01700] |
Source(1):